NEUROG3

neurogenin 3, the group of Basic helix-loop-helix proteins

Basic information

Region (hg38): 10:69571698-69573422

Links

ENSG00000122859NCBI:50674OMIM:604882HGNC:13806Uniprot:Q9Y4Z2AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • permanent neonatal diabetes mellitus (Strong), mode of inheritance: AR
  • congenital malabsorptive diarrhea 4 (Strong), mode of inheritance: AR
  • congenital malabsorptive diarrhea 4 (Strong), mode of inheritance: AR
  • congenital malabsorptive diarrhea 4 (Strong), mode of inheritance: AR
  • congenital malabsorptive diarrhea 4 (Supportive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Diarrhea 4, malabsorptive, congenitalARGastrointestinalIndividuals may present in infancy with severe hyperchloremic metabolic acidosis due to vomiting and diarrhea, and may require parenteral nutrition and limited enteral feeding (with oral vitamins and electrolyte supplementation); Surveillance may allow early recognition and treatment of diabetes mellitus (including with insulin); One reported individual required liver/intestinal transplantEndocrine; Gastrointestinal16855267; 21490072

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NEUROG3 gene.

  • not_provided (123 variants)
  • Inborn_genetic_diseases (33 variants)
  • Congenital_malabsorptive_diarrhea_4 (15 variants)
  • NEUROG3-related_disorder (4 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NEUROG3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000020999.4. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
46
clinvar
2
clinvar
48
missense
2
clinvar
4
clinvar
80
clinvar
4
clinvar
1
clinvar
91
nonsense
3
clinvar
1
clinvar
1
clinvar
5
start loss
0
frameshift
2
clinvar
1
clinvar
3
clinvar
6
splice donor/acceptor (+/-2bp)
0
Total 7 6 84 50 3

Highest pathogenic variant AF is 0.000012391298

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NEUROG3protein_codingprotein_codingENST00000242462 11541
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000005960.1511256810321257130.000127
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.5171431271.130.000005951325
Missense in Polyphen3937.9621.0273421
Synonymous-0.4916459.21.080.00000287495
Loss of Function-0.68675.301.322.46e-749

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004130.000410
Ashkenazi Jewish0.000.00
East Asian0.0001640.000163
Finnish0.00004630.0000462
European (Non-Finnish)0.00004470.0000440
Middle Eastern0.0001640.000163
South Asian0.0003350.000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Acts as a transcriptional regulator. Together with NKX2- 2, initiates transcriptional activation of NEUROD1. Involved in neurogenesis. Also required for the specification of a common precursor of the 4 pancreatic endocrine cell types (By similarity). {ECO:0000250}.;
Disease
DISEASE: Diarrhea 4, malabsorptive, congenital (DIAR4) [MIM:610370]: A disease characterized by severe, life-threatening watery diarrhea associated with generalized malabsorption and a paucity of enteroendocrine cells. {ECO:0000269|PubMed:16855267}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Maturity onset diabetes of the young - Homo sapiens (human);Notch-mediated HES/HEY network (Consensus)

Recessive Scores

pRec
0.200

Intolerance Scores

loftool
0.381
rvis_EVS
0.24
rvis_percentile_EVS
68.98

Haploinsufficiency Scores

pHI
0.0709
hipred
N
hipred_score
0.290
ghis
0.392

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.283

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Neurog3
Phenotype
renal/urinary system phenotype; digestive/alimentary phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype;

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;nervous system development;central nervous system development;peripheral nervous system development;spinal cord development;epithelial cell differentiation;forebrain development;hindbrain development;endocrine pancreas development;positive regulation of neuron differentiation;positive regulation of transcription by RNA polymerase II;regulation of dendrite morphogenesis;positive regulation of DNA-binding transcription factor activity;transdifferentiation
Cellular component
nucleus;cytoplasm
Molecular function
RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;transcription coactivator activity;protein binding;chromatin DNA binding;protein dimerization activity